
Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors
Author(s) -
Shengwei Mo,
Liju Zong,
Xianlong Chen,
Xinchao Ban,
Mei Li,
Zhaohui Lü,
Shuangni Yu,
Jie Chen
Publication year - 2022
Publication title -
archives of pathology and laboratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.79
H-Index - 117
eISSN - 1543-2165
pISSN - 0003-9985
DOI - 10.5858/arpa.2021-0377-oa
Subject(s) - stromal cell , immunohistochemistry , tissue microarray , neuroendocrine tumors , immune system , pathology , pd l1 , medicine , cancer research , biology , immunology , immunotherapy
Pancreatic neuroendocrine tumors (PanNETs) are rare malignancies with heterogeneous clinical courses requiring novel prognosticators and therapies. B7 family molecules have an important role in various cancers; however, these have not been distinguished in PanNETs.